Supernus Pharmaceuticals Current Deferred Revenue (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

49.82 -1.43 (-2.79%) USD | NASDAQ | Dec 30, 16:00

49.82 0.00 (0.00%) After-Hours: 17:46

View Current Deferred Revenue (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

BridgeBio Pharma, Inc.	Upgrade
The Cooper Cos., Inc.	Upgrade
Assembly Biosciences, Inc.	Upgrade
Amphastar Pharmaceuticals, Inc.	--
Viking Therapeutics, Inc.	--